Related Experiment Video

Updated: Aug 28, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Correction: Serial ctDNA dynamics predict clinical outcomes in metastatic and locally advanced PDAC: a systematic

Supriya Peshin1, Ehab Takrori2, Ibrahim Halil Sahin3

  • 1Department of Internal Medicine, Norton Community Hospital, Norton, VA, United States.

Frontiers in Oncology
|August 27, 2026
PubMed

Keywords:
CA19-9circulating tumor DNAearly molecular responseliquid biopsylongitudinal monitoringminimal residual diseaseoverall survivalpancreatic ductal adenocarcinoma

More Related Videos

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency07:08

Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency

Published on: February 2, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...